Climate Change Data

Seegene, Inc.

Climate Impact & Sustainability Data (2021, 2022, 2023)

Reporting Period: 2021

Environmental Metrics

Total Carbon Emissions:4,476 tonCO2eq
Scope 2 Emissions:4,476 tonCO2eq
Renewable Energy Share:0%
Total Energy Consumption:93.5 TJ
Water Consumption:24,879 tons
Waste Generated:90 tons
Carbon Intensity:0.39 tonCO2eq/KRW 100 million

ESG Focus Areas

  • Business innovation
  • Product stewardship
  • Supply chain management
  • Capacity building for employees and nurturing industry experts
  • Establishing a culture of great workplace
  • Strengthening shareholder/governance responsibility
  • Bolstering workplace health and safety management
  • Improving ESG disclosure and communication
  • Reducing waste generation
  • Strengthening GHG emissions reduction management
  • Establishing an environmental management system
  • Enhancing business ethics
  • Efficient remuneration system for management
  • Strengthening financial/non-financial risk management
  • Enhancing customer data privacy
  • Implementing strategic corporate citizenship activities

Environmental Achievements

  • Reduced Styrofoam waste by shifting to multi-use containers for product shipment
  • Replaced a portion of packaging materials with eco-certified ones (KRW 16.4 million spent in 2021)

Social Achievements

  • Hired 302 new R&D employees (50.1% of total workforce)
  • Established an employee training system and a self-initiated learning platform
  • Operated a degree support program
  • Created a training program to share Seegene’s values and culture
  • Established and operated a communication platform to improve organizational culture
  • Declared commitment to human rights management and operated the Grievance Counseling Center
  • Donated KRW 4 billion to the Community Chest of Korea in 2020 and KRW 4.995 billion in 2021 (including donations of diagnostic kits and instruments)

Governance Achievements

  • Improved internal accounting control system
  • Stipulated and/or amended internal accounting control regulations, internal accounting control operational guidelines, compliance control standards, compliance control standards implementation guidelines, and internal audit regulations
  • Appointed the Compliance Officer
  • Created a dedicated compliance support organization
  • Strengthened the management of domestic/overseas sales channels through tighter compliance management
  • Provided compliance training

Climate Goals & Targets

Environmental Challenges

  • Shortage of diagnostic kits amid the surge in confirmed COVID-19 cases
  • Increasing risk faced by the healthcare system which completely relies upon global supply chains
  • Healthcare professionals commented on the possibility of bleeding among infants during PCR testing and the need for collecting saliva/throat specimens
Mitigation Strategies
  • Established overseas subsidiaries
  • Successfully entered the global public procurement market
  • Developed a diagnostic kit capable of differentiating infections caused by COVID-19 variants
  • Combined saliva testing with COVID-19 diagnostic kits

Supply Chain Management

Supplier Audits: Around 60% of Seegene’s third-party warehouse suppliers have been certified under the (KGSP) Korea Good Supplying Practice program.

Responsible Procurement
  • Partner Code of Conduct (covering labor, human rights, health & safety, environmental protection, supply chain, and compliance with ethical standards)

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards (Core options), SASB

Third-party Assurance: Korea Management Registrar

Awards & Recognition

  • Youth-friendly Hidden Champion (Ministry of Employment and Labor)
  • 2020 LMCE Plague of Appreciation (Korean Society for Laboratory Medicine)
  • Korea Job Achievement Award (Presidential Committee on Jobs)
  • 2021 Youth-friendly Hidden Champion (Ministry of Employment and Labor)
  • 2021 LMCE Plague of Appreciation (Korean Society for Laboratory Medicine)
  • 2021 Innovative Medical Device Maker Award – Minister Prize (Ministry of Health and Welfare)
  • 2021 SW Quality Innovation Award – Minister Prize (Ministry of Science and ICT)
  • USD 1 Billion Export Tower on the 58th Trade Day (Ministry of Trade, Industry and Energy)
  • Brand Top on the 58th Trade Day – Allplex (Ministry of Trade, Industry and Energy)
  • Excellent Institution for Supporting the Overseas Expansion of Medical Business in 2021 (Korea Health Industry Development Institute)
  • Venture Company Achieving KRW 100 billion in Sales (Ministry of SMEs and Startups)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:6,748 tCO2e/year
Scope 1 Emissions:0 tCO2e/year
Scope 2 Emissions:6,748 tCO2e/year
Renewable Energy Share:0%
Total Energy Consumption:135.5 TJ/year
Water Consumption:37,984 tons/year
Waste Generated:161 tons/year
Carbon Intensity:0.96 tonCO2eq/KRW billion

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Developed a new patented eco-friendly packaging box, replacing Styrofoam boxes and improving thermal insulation by 25% while reducing transportation costs by 12%
  • Increased purchase of eco-friendly packaging materials by 55%

Social Achievements

  • Established the ESG Committee under the Board of Directors
  • Provided ESG internalization training to raise employee awareness
  • Launched AIOSTM (All-in-One System) that fully automates the PCR process
  • Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay obtained approval in the EU for its application to AIOS
  • Allplex™ SARS-CoV-2 Assay was awarded the ‘Product of the Year Award’ at the BioSpectrum Asia Excellence Awards in 2022

Governance Achievements

  • Established the ESG Committee under the Board of Directors to oversee ESG management
  • Implemented ethical/compliance management and fully disclosed ESG activities and achievements to stakeholders
  • Made quarterly dividend payments and repurchased treasury shares to bolster shareholder value
  • Upgraded information security system through server/DB access control, DB encryption, server vaccine installation, and web firewall deployment
  • Established a company-wide chemical substance management system

Climate Goals & Targets

Environmental Challenges

  • Transition of COVID-19 from pandemic to endemic impacted sales of COVID-19-associated products
  • Intensifying competition to attract talent in the biopharmaceutical industry
  • Increasing human rights/labor rights risks in line with tightening human rights regulations
  • Increasing costs and management risks in line with tightening supply chain management regulations
  • Expanding risk of responding to tightening health and safety laws and regulations
  • Increasing stakeholder expectations for corporate social responsibility
  • Tightening information security regulations
  • Increasing issues to respond to tightening environmental laws and regulations
Mitigation Strategies
  • Focused on promoting a wide range of syndromic test products and automation instrumentation business, resulting in a 31% year-over-year growth of non-COVID products
  • Systematically managing training to assist employees in building their capacity and developing into professionals
  • Launched SG OneSystemTM to establish a collaboration network to share Seegene’s syndromic PCR technology
  • Rigorously managing clinical trials in conformity with IRB regulations and monitoring the entire product lifecycle
  • Established the ESG Committee under the Board of Directors to oversee ESG-related issues
  • Implemented ethical/compliance management and fully disclosed ESG activities and achievements to stakeholders
  • Improved vulnerabilities through remote web firewall monitoring, assessing corporate data leaks, and reviewing production equipment for vulnerabilities
  • Established an environmental management system and stipulated the environmental management policy
  • Purchased eco-friendly packaging materials and developed eco-friendly packaging

Supply Chain Management

Supplier Audits: Regular annual assessments, including ESG categories since 2022

Responsible Procurement
  • Partner Code of Conduct covering labor, human rights, health & safety, environmental protection, supply chain, and compliance with ethical standards

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards, ISSB, SASB (Medical Equipment & Suppliers industry standard), UN SDGs

Third-party Assurance: BSI (British Standards Institution)

Sustainable Products & Innovation

  • Eco-friendly packaging box

Awards & Recognition

  • Allplex™ SARS-CoV-2 Assay: ‘Product of the Year Award’ at the BioSpectrum Asia Excellence Awards in 2022

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:6,845 tonCO2eq/year
Scope 1 Emissions:0 tonCO2eq/year
Scope 2 Emissions:6,845 tonCO2eq/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:0%
Total Energy Consumption:137.5 TJ/year
Water Consumption:51,506 tons/year
Waste Generated:497 tons/year
Carbon Intensity:2.51 tonCO2eq/KRW 100 million in 2023

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Developed and patented recyclable, eco-friendly packaging boxes in 2022.
  • Obtained ISO 45001 certification for nine business sites.

Social Achievements

  • Opened Seegene Daycare Center.
  • Conducted first human rights impact assessment.
  • Launched Technology-Sharing Initiative and Open Innovation Program.

Governance Achievements

  • Established ESG Committee under the Board of Directors.
  • Transitioned from a single representative system to a joint representative system.
  • Achieved 100% BOD attendance rate.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Complete processes for all in-house oligonucleotides by 2025.
  • Commercialize nucleic acid extraction reagent products compatible with automated diagnostic equipment by 2025.

Environmental Challenges

  • Decline in COVID-19-related product sales.
  • Intensified competition in the pharmaceutical and biotechnology industry.
  • Global economic downturns and wars.
Mitigation Strategies
  • Focused on reducing dependence on COVID-19 related products by introducing syndromic testing products and increasing mass testing through automated equipment.
  • Launched Technology-Sharing Initiative and Open Innovation Program to secure future growth drivers.
  • Strengthened internal control systems to protect against risks.

Supply Chain Management

Supplier Audits: 100% of equipment suppliers audited regularly.

Responsible Procurement
  • Partner Code of Conduct
  • Annual supplier evaluations
  • ESG capability management of suppliers

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather phenomena
Transition Risks
  • Fortified climate change and environmental regulations
  • Climate response capabilities considered as determining factor of contract signing/extension
Opportunities
  • Improving energy efficiency
  • Creating new markets for climate change-related diseases

Reporting Standards

Frameworks Used: GRI Standards, SASB guidelines for Medical Equipment & Supplies sector, TCFD recommendations, UN SDGs

Certifications: ISO 13485, ISO 9001, ISO 45001, MDSAP, KGMP

Third-party Assurance: British Standards Institution (BSI)

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Recyclable packaging boxes
  • Improved enzyme master mixes

Awards & Recognition

  • Platinum Award LACP 2023 Spotlight Awards